Insights

Regulatory-Research Fit Position PEI as a unique partner that combines regulatory oversight with cutting-edge biomedicine research. Sales opportunities exist in collaboration on clinical trial approvals, pharmacovigilance services, official batch testing, scientific advisory, and inspections for vaccine and biomedicine programs.

Public Health Mandate Leverage PEI's role in national and international health initiatives to offer consulting or managed services around regulatory compliance, international mandates (WHO, EMA, EC), and capacity-building projects in vaccine and immunology biosafety.

Global Collaboration Target partnerships with CEPI, WAHO, and other health authorities for regulatory strengthening projects like ECOWASRegECs. Opportunities exist in funded programs, regulatory ethics oversight, and preparedness activities in West Africa and similar regions.

Digital and ERP Fit With a modern tech stack including SAP FICO, Microsoft Dynamics, iCIMS, and analytics tools, offer integrated compliance, financial reporting optimization, and HR/talent management enhancements to streamline grant management, audits, and clinical trial operations.

Vaccine & Biomedicine Focus Explore partnerships around vaccine development, biomedicine testing, and pharmacovigilance services. Potential sales targets include contract research, official batch testing with regulatory requirements, and advisory services to accelerate safe, effective product approvals.

Similar companies to Paul-Ehrlich-Institut

Paul-Ehrlich-Institut Tech Stack

Paul-Ehrlich-Institut uses 8 technology products and services including SAP FICO, DATEV, iCIMS, and more. Explore Paul-Ehrlich-Institut's tech stack below.

Media & News

Paul-Ehrlich-Institut's Email Address Formats

Paul-Ehrlich-Institut uses at least 4 email formats:
Paul-Ehrlich-Institut Email FormatsExamplePercentage
First.Last@pei.deJohn.Doe@pei.de
83%
Last.First@pei.deDoe.John@pei.de
8%
FLast@pei.deJDoe@pei.de
6%
First_Last@pei.deJohn_Doe@pei.de
3%

Frequently Asked Questions

What is Paul-Ehrlich-Institut's official website and social media links?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut's official website is pei.de and has social profiles on LinkedIn.

How much revenue does Paul-Ehrlich-Institut generate?

Minus sign iconPlus sign icon
As of October 2026, Paul-Ehrlich-Institut's annual revenue is estimated to be $25M - $50M.

What is Paul-Ehrlich-Institut's NAICS code?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does Paul-Ehrlich-Institut have currently?

Minus sign iconPlus sign icon
As of October 2026, Paul-Ehrlich-Institut has approximately 473 employees across 3 continents, including Europe, North America and Asia. Key team members include President: S. V., Head Of Media And Public Relations: C. L. and Head Of Unit Procurement And Logistics: M. S. Explore Paul-Ehrlich-Institut's employee directory with LeadIQ.

What industry does Paul-Ehrlich-Institut belong to?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut operates in the Research Services industry.

What technology does Paul-Ehrlich-Institut use?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut's tech stack includes SAP FICO, DATEV, iCIMS, Microsoft Dynamics, Microsoft, Piwik, Microsoft Teams and Piwik PRO Core.

What is Paul-Ehrlich-Institut's email format?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut's email format typically follows the pattern of First.Last@pei.de. Find more Paul-Ehrlich-Institut email formats with LeadIQ.
Paul-Ehrlich-Institut logo

Paul-Ehrlich-Institut

Research ServicesHesse, Germany201-500 Employees

The Paul-Ehrlich-Institut is Germany’s Federal Institute for Vaccines and Biomedicines, combining regulatory responsibilities with active biomedical research. Based near Frankfurt in Langen, it operates under the Federal Ministry of Health and conducts research on biomedicines for humans and veterinary immunological products while also granting authorisations when benefits outweigh risks. The institute oversees clinical trial approvals, pharmacovigilance, official batch testing, scientific advice, and inspections, supporting public health through rigorous evaluation and monitoring of medicinal products. In addition to its regulatory duties, it engages in independent experimental research that informs and underpins its regulatory activities, aiming to improve access to safe, effective, and high-quality biomedicines. The organization collaborates with international bodies and contributes expert guidance to entities such as the WHO, EMA, and the European Commission, reflecting its dual role in science and regulation. A recent collaboration highlighted its ongoing international engagement, exemplified by partnerships and joint projects with global health organizations. The institute employs staff across its research and regulatory functions, reflecting its broad scope and public health mandate. } ) } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } }

Section iconCompany Overview

Website
pei.de
NAICS Code
5417 - Scientific Research and Development Services
Employees
201-500

Section iconFunding & Financials

  • $25M - $50M

    Paul-Ehrlich-Institut's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.